The inhibition of GCS also increases ceramide levels [67], as does the marked increase of GBA2 activity in the spinal cord, allowing the hypothesis that GBA2 inhibitors will be beneficial in ALS (see below). The gene discussed is GBA2; the disease is amyotrophic lateral sclerosis.